Management of Neuromuscular Blocking Agents in Critically Ill Patients with Lung Diseases
The use of neuromuscular blocking agents (NMBAs) is common in the intensive care unit (ICU). NMBAs have been used in critically ill patients with lung diseases to optimize mechanical ventilation, prevent spontaneous respiratory efforts, reduce the work of breathing and oxygen consumption, and avoid...
Main Authors: | Ida Giorgia Iavarone, Lou’i Al-Husinat, Jorge Luis Vélez-Páez, Chiara Robba, Pedro Leme Silva, Patricia R. M. Rocco, Denise Battaglini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/4/1182 |
Similar Items
-
Use of Sedatives and Neuromuscular-Blocking Agents in Mechanically Ventilated Patients with COVID-19 ARDS
by: Amédée Ego, et al.
Published: (2021-11-01) -
Hematuria during prolonged administration of ketamine to treat bronchospasm and respiratory failure in a toddler.
by: M. Zlotolow, et al.
Published: (2023-08-01) -
A surgeon′s assessment of inadequate neuromuscular antagonism in a case of prolonged neuromuscular blockade
by: James J Lamberg, et al.
Published: (2013-01-01) -
Examining influences of neuromuscular block post tetanic monitoring technique on the quality of surgical conditions: Neuromuscular block and quality of surgical conditions
by: Janković Radmilo, et al.
Published: (2016-01-01) -
New way of dosing sugammadex for termination of vecuronium induced neuromuscular block
by: Blaž Peček, et al.
Published: (2015-06-01)